 |
C1-esterase-inhibitor, human, pasteurized |
|---|---|
| Trade Name | Haegarda |
| Orphan Indication | Prevention and/or treatment of acute attacks of hereditary angioedema |
| USA Market Approval | USA |
| USA Designation Date | 1992-10-16 00:00:00 |
| Sponsor | CSL Behring LLC;1020 First Ave., PO Box 61501;King of Prussia, Pennsylvania, 19406 |
